Why Doctors Without Borders Is Lobbying Against Obama’s Trade Deal - NationalJournal.com
"One of the general criticisms of drug regulations and patent law in many Western countries is that they prevent generic drugs from entering the market for years or even decades and otherwise stifle competition, which keep drug prices high. The pharmaceutical industry counters by arguing that firms need to be able to recoup their investments for failed as well as successful drugs so they can continue pursuing research on new medicines, and market exclusivity helps them do that."
No comments:
Post a Comment